{"id":17839,"date":"2026-01-23T15:23:08","date_gmt":"2026-01-23T14:23:08","guid":{"rendered":"https:\/\/www.bm-t.de\/2023-en\/altavo-concludes-series-a2-for-the-development-of-its-artificial-voice\/"},"modified":"2026-01-23T15:27:47","modified_gmt":"2026-01-23T14:27:47","slug":"altavo-concludes-series-a2-for-the-development-of-its-artificial-voice","status":"publish","type":"post","link":"https:\/\/www.bm-t.de\/en\/2026\/altavo-concludes-series-a2-for-the-development-of-its-artificial-voice\/","title":{"rendered":"Altavo concludes Series A2 for the development of its Artificial Voice"},"content":{"rendered":"

Altavo GmbH, a med\u00adical tech\u00adnol\u00adogy startup for AI-based voice reha\u00adbil\u00adi\u00adta\u00adtion, suc\u00adcess\u00adfully closed a Series A2 financ\u00ading round on Jan\u00adu\u00adary 12, 2026. A Euro\u00adpean con\u00adsor\u00adtium led by Novalis Biotech and bm|t is invest\u00ading \u20ac 3 mil\u00adlion in the devel\u00adop\u00adment of Altavo\u2019s inno\u00adv\u00ada\u00adtive arti\u00adfi\u00adcial voice. <\/strong><\/p>\n

Altavo\u2019s arti\u00adfi\u00adcial voice is designed to give voice\u00adless peo\u00adple their own nat\u00adural-sound\u00ading voice, for exam\u00adple after a laryn\u00adgec\u00adtomy or dur\u00ading arti\u00adfi\u00adcial res\u00adpi\u00adra\u00adtion. The \u201cSilent Speech\u201d tech\u00adnol\u00adogy devel\u00adoped for this pur\u00adpose in col\u00adlab\u00ado\u00adra\u00adtion with researchers at the Tech\u00adni\u00adcal Uni\u00adver\u00adsity of Dres\u00adden is based on non-inva\u00adsive radar sen\u00adsors and the lat\u00adest AI algorithms.<\/p>\n

In addi\u00adtion to the two lead investors Novalis Biotech (Ghent, Bel\u00adgium) and bm|t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen, other investors in the cur\u00adrent round include: TGFS Tech\u00adnolo\u00adgiegr\u00fcn\u00adder\u00adfonds Sach\u00adsen, High-Tech Gr\u00fcn\u00adder\u00adfonds (HTGF), TUDAG TU Dres\u00adden AG, Ost\u00adwerk GmbH and pri\u00advate indi\u00advid\u00adual investors.<\/p>\n

The now com\u00adpleted Series A2 will finance the fur\u00adther estab\u00adlish\u00adment of the com\u00adpany, clin\u00adi\u00adcal study work and the devel\u00adop\u00adment of the series prod\u00aduct. Altavo\u2019s tech\u00adnol\u00adogy has the poten\u00adtial to improve the qual\u00adity of life of voice\u00adless peo\u00adple and fun\u00adda\u00admen\u00adtally opens up new pos\u00adsi\u00adbil\u00adi\u00adties in silent inter\u00adac\u00adtion between peo\u00adple and technology.<\/p>\n

\u201cWe are delighted with the strong back\u00ading from our exist\u00ading Euro\u00adpean investor base and the new investors who have come on board in this round. With the A2 round, we are ide\u00adally posi\u00adtioned for the next steps on the road to an arti\u00adfi\u00adcial voice for voice\u00adless people.\u201d<\/em><\/p>\n

Rudolf von B\u00fcnau, Man\u00adag\u00ading Direc\u00adtor and co-founder, Altavo GmbH<\/p>\n

\u201cAltavo\u2019s devel\u00adop\u00admen\u00adtal and clin\u00adi\u00adcal progress and its expe\u00adri\u00adenced man\u00adage\u00adment team con\u00advinced us to also par\u00adtic\u00adi\u00adpate in the A2 round \u2014 together with bm|t in the role of co-lead investor.\u201d<\/em><\/p>\n

Jaroslav Belot\u00adserkovsky, Invest\u00adment Man\u00adager, Novalis Biotech<\/p>\n

\u201cAltavo remains a prime exam\u00adple of the trans\u00adla\u00adtion of uni\u00adver\u00adsity research into start-up com\u00adpa\u00adnies and of suc\u00adcess\u00adful fund\u00ading pol\u00adicy in Cen\u00adtral Ger\u00admany, beyond the bor\u00adders of the fed\u00aderal state. We are delighted to be able to sup\u00adport the expe\u00adri\u00adenced Altavo team in real\u00adiz\u00ading its ambi\u00adtious vision.\u201d <\/em><\/p>\n

Michael Thiele, Invest\u00adment Man\u00adager, bm |t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen gmbh and S\u00f6ren Schus\u00adter, Man\u00adag\u00ading Direc\u00adtor, TGFS Tech\u00adnolo\u00adgiegr\u00fcn\u00adder\u00adfonds Sachsen<\/p>\n

 <\/p>\n

Altavo team (Image: Altavo)<\/figcaption><\/figure>\n

About Altavo<\/strong><\/h4>\n

Altavo GmbH is a med\u00adical tech\u00adnol\u00adogy start-up founded in Feb\u00adru\u00adary 2021 and based in Dres\u00adden. Based on non-inva\u00adsive radar sen\u00adsor tech\u00adnol\u00adogy and arti\u00adfi\u00adcial intel\u00adli\u00adgence, Altavo devel\u00adops pros\u00adthet\u00adics to improve the reha\u00adbil\u00adi\u00adta\u00adtion of voice\u00adless and vocally impaired patients. At its loca\u00adtions in Dres\u00adden and Jena, Altavo cur\u00adrently employs 16 peo\u00adple with many years of expe\u00adri\u00adence in the fields of AI \/ data sci\u00adence, speech tech\u00adnol\u00adogy, high-fre\u00adquency tech\u00adnol\u00adogy, med\u00adical tech\u00adnol\u00adogy and voice therapy.<\/p>\n

Altavo coop\u00ader\u00adates with the Chair of Lan\u00adguage Tech\u00adnol\u00adogy and Cog\u00adni\u00adtive Sys\u00adtems and the Chair of High Fre\u00adquency Tech\u00adnol\u00adogy at the Tech\u00adni\u00adcal Uni\u00adver\u00adsity of Dres\u00adden. The col\u00adlab\u00ado\u00adra\u00adtion is funded by the Free State of Sax\u00adony and co-financed by the Euro\u00adpean Union as part of the SEMECO Future Clus\u00adter in the \u201cB3 \/ MUSIK\u201d project.<\/p>\n

Press con\u00adtact: Rudolf v. B\u00fcnau, rudolf.vonbuenau@altavo.eu<\/u><\/p>\n

 <\/p>\n

About Novalis Biotech<\/strong><\/h4>\n

Novalis Biotech (Ghent, Bel\u00adgium) is an early-stage ven\u00adture cap\u00adi\u00adtal investor that invests in tech\u00adnolo\u00adgies that are rev\u00ado\u00adlu\u00adtion\u00adiz\u00ading health\u00adcare. The com\u00adpa\u00adny\u2019s core com\u00adpe\u00adtence lies in the dig\u00adi\u00adtal\u00adiza\u00adtion of life sci\u00adences, with a focus on bioin\u00adfor\u00admat\u00adics, genomics and diag\u00adnos\u00adtics. Novalis believes in the appli\u00adca\u00adtion of inno\u00adv\u00ada\u00adtive tech\u00adnolo\u00adgies to advance the pre\u00adven\u00adtion, diag\u00adno\u00adsis or treat\u00adment of diseases.<\/p>\n

For more infor\u00adma\u00adtion, please visit www.noval.is<\/u><\/p>\n

 <\/p>\n

About bm | t beteiligungsmanagement th\u00fcringen<\/strong><\/h4>\n

bm | t, based in Erfurt, is the lead\u00ading address for ven\u00adture cap\u00adi\u00adtal invest\u00adments in Thuringia. bm | t cur\u00adrently man\u00adages 13 funds with a total vol\u00adume of around EUR 465 mil\u00adlion, which invest in inno\u00adv\u00ada\u00adtive com\u00adpa\u00adnies in almost all sec\u00adtors and in all phases of com\u00adpany devel\u00adop\u00adment \u2014 both in the start-up and growth phases or in com\u00adpany suc\u00adces\u00adsion situations.<\/p>\n

Fur\u00adther infor\u00adma\u00adtion can be found at www.bm\u2011t.de<\/u><\/p>\n

Press con\u00adtact: Michael Thiele, michael.thiele@bm\u2011t.de<\/u><\/p>\n

 <\/p>\n

About the TGFS Technologiegr\u00fcnderfonds Sachsen<\/strong><\/h4>\n

TGFS is an equity investor for knowl\u00adedge-based, tech\u00adnol\u00adogy-ori\u00adented start-ups in Sax\u00adony. It is the lead\u00ading start-up financier in the Free State of Sax\u00adony and sup\u00adports teams with ven\u00adture cap\u00adi\u00adtal and man\u00adage\u00adment sup\u00adport in both the seed and start-up phases. An invest\u00adment by TGFS gives port\u00adfo\u00adlio com\u00adpa\u00adnies access to other inter\u00adna\u00adtional investors.<\/p>\n

The fund was first launched in 2008 by the Free State of Sax\u00adony (with ERDF fund\u00ading, among other things) and Saxon finan\u00adcial insti\u00adtu\u00adtions and has since sup\u00adported over 100 start-ups in what is now the third gen\u00ader\u00ada\u00adtion of the fund.<\/p>\n

Press con\u00adtact: S\u00f6ren Schus\u00adter, Phone +49 172 2001097, soeren.schuster@cfh.de<\/u><\/p>\n

 <\/p>\n

About the HTGF \u2014 High-Tech Gr\u00fcnderfonds<\/strong><\/h4>\n

HTGF is one of the lead\u00ading and most active early-stage investors in Ger\u00admany and Europe, financ\u00ading start-ups in the fields of deep tech, indus\u00adtrial tech, cli\u00admate tech, dig\u00adi\u00adtal tech, life sci\u00adences and chem\u00adi\u00adcals. With its expe\u00adri\u00adenced invest\u00adment team, HTGF sup\u00adports star\u00adtups in all phases of their devel\u00adop\u00adment into inter\u00adna\u00adtional mar\u00adket lead\u00aders. HTGF invests in the pre-seed and seed phase and can make sig\u00adnif\u00adi\u00adcant invest\u00adments in fur\u00adther financ\u00ading rounds. Since its foun\u00adda\u00adtion in 2005, it has financed around 800 start-ups and real\u00adized 200 suc\u00adcess\u00adful exits. HTGF has a fund vol\u00adume of over 2 bil\u00adlion euros.<\/p>\n

Fund investors in the pub\u00adlic-pri\u00advate part\u00adner\u00adship include the Ger\u00adman Fed\u00aderal Min\u00adistry for Eco\u00adnomic Affairs and Energy, KfW Cap\u00adi\u00adtal and 45 com\u00adpa\u00adnies and fam\u00adily offices.<\/p>\n

Fur\u00adther infor\u00adma\u00adtion can be found at www.HTGF.de.<\/u><\/p>\n

Press con\u00adtact: Tobias Jacob, Senior Mar\u00adket\u00ading & Com\u00admu\u00adni\u00adca\u00adtions Man\u00adager, Phone +49 228 82300 121, t.jacob@htgf.de<\/u><\/p>\n

 <\/p>\n

About Ostwerk<\/strong><\/h4>\n

Ost\u00adwerk GmbH is a wholly owned sub\u00adsidiary of Sparda-Bank Berlin eG, an invest\u00adment com\u00adpany founded in 2024 and based in Berlin. As a part\u00adner\u00adship investor, the com\u00adpany invests equity in young com\u00adpa\u00adnies that want to ful\u00adfill their regional respon\u00adsi\u00adbil\u00adity in a sus\u00adtain\u00adable man\u00adner and thus cre\u00adate future prospects in east\u00adern Ger\u00admany. The com\u00adpany com\u00adbines finan\u00adcial invest\u00adment with strate\u00adgic sup\u00adport and a value- and net\u00adwork-based approach to enable long-term eco\u00adnomic and social devel\u00adop\u00adment. Ost\u00adwerk is active in all six east\u00adern Ger\u00adman states and is aimed specif\u00adi\u00adcally at young com\u00adpa\u00adnies with regional and social aspirations.<\/p>\n

Press con\u00adtact: Johannes Ulrich and Franz Neu\u00admann (Man\u00adag\u00ading Direc\u00adtors), hallo@ost-werk.de,<\/u> www.ost-werk.de<\/u><\/p>\n","protected":false},"excerpt":{"rendered":"

Altavo GmbH, a med\u00adical tech\u00adnol\u00adogy startup for AI-based voice reha\u00adbil\u00adi\u00adta\u00adtion, has closed a Series A2 financ\u00ading round. A Euro\u00adpean con\u00adsor\u00adtium led by Novalis Biotech and bm|t is invest\u00ading \u20ac 3 mil\u00adlion in the devel\u00adop\u00adment of Altavo\u2019s inno\u00adv\u00ada\u00adtive arti\u00adfi\u00adcial voice. <\/p>\n","protected":false},"author":2,"featured_media":17838,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[288],"tags":[159,176,177,210,289],"class_list":["post-17839","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-288","tag-investment-en","tag-bm-t-en","tag-bmt-en","tag-investeepartner","tag-financing-round"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/17839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/comments?post=17839"}],"version-history":[{"count":1,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/17839\/revisions"}],"predecessor-version":[{"id":17841,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/17839\/revisions\/17841"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media\/17838"}],"wp:attachment":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media?parent=17839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/categories?post=17839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/tags?post=17839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}